How could a change in the base sequence of the mRNA lead to a change in the tertiary structure of the toxin?

How could a change in the base sequence of the mRNA lead to a change in the tertiary structure of the toxin?

• A. Different amino acid sequence that alters folding
• B. No change in the amino acid sequence
• C. The mRNA becomes longer
• D. The protein is unchanged due to chaperones

Answer: (A)

A protein’s three-dimensional shape is determined by its amino acid sequence, which is set by the mRNA codons that are read during translation. If a change in the mRNA base sequence alters a codon so that a different amino acid is incorporated (a missense change), the primary structure of the toxin changes. That new amino acid changes the chemical properties at that position—size, charge, hydrophobicity, or ability to form certain bonds—so the pattern of interactions among all side chains during folding is different. Since tertiary structure arises from these cumulative interactions (hydrophobic collapse, hydrogen bonds, ionic interactions, disulfide bridges, etc.), even a single amino acid substitution can shift the folding path and yield a different final 3D shape. This can alter the toxin’s activity or stability. The other scenarios don’t explain the linkage as directly. Making mRNA longer isn’t a guaranteed driver of a different final fold, unless it changes the protein length or reading frame. Chaperones help folding but can’t fully override a changed amino acid sequence, and a base change that doesn’t alter the amino acid sequence (a silent mutation) would not change the folding driven by primary structure.

A protein’s three-dimensional shape is determined by its amino acid sequence, which is set by the mRNA codons that are read during translation. If a change in the mRNA base sequence alters a codon so that a different amino acid is incorporated (a missense change), the primary structure of the toxin changes. That new amino acid changes the chemical properties at that position—size, charge, hydrophobicity, or ability to form certain bonds—so the pattern of interactions among all side chains during folding is different. Since tertiary structure arises from these cumulative interactions (hydrophobic collapse, hydrogen bonds, ionic interactions, disulfide bridges, etc.), even a single amino acid substitution can shift the folding path and yield a different final 3D shape. This can alter the toxin’s activity or stability.

The other scenarios don’t explain the linkage as directly. Making mRNA longer isn’t a guaranteed driver of a different final fold, unless it changes the protein length or reading frame. Chaperones help folding but can’t fully override a changed amino acid sequence, and a base change that doesn’t alter the amino acid sequence (a silent mutation) would not change the folding driven by primary structure.